Regeneron Pharmaceuticals REGN
$ 828.84
-1.75%
Quarterly report 2024-Q3
added 10-31-2024
Regeneron Pharmaceuticals Total Current Liabilities 2011-2024 | REGN
Annual Total Current Liabilities Regeneron Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3.42 B | 3.14 B | 3.93 B | 2.7 B | 2.1 B | 1.44 B | 1.14 B | 1.24 B | 811 M | 655 M | 299 M | 164 M | 148 M |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
3.93 B | 148 M | 1.63 B |